Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

This study has been completed.
Human Genome Center, Institute of Medical Science, University of Tokyo
Information provided by:
Wakayama Medical University Identifier:
First received: February 13, 2008
Last updated: February 17, 2009
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
No publications provided by Wakayama Medical University

Publications automatically indexed to this study by Identifier (NCT Number):